Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo.
Thromboembolic complications occurring in patients treated with factor IX concentrates have been reported. To study the thrombogenicity various types of factor IX concentrates (50 or 100 units F. IX/kg bodyweight) have been infused in dogs. As control albumin was given. The various components of the coagulation and fibrinolytic system have been assayed before the infusion and at various intervals after the end of infusion (0, 1, 4 and 24 hrs). Konyne resulted in marked activation of the coagulation process with decrease of platelets, fibrinogen, F. VIII and appearance of FDP and positive ethanol gelation test. Prothromplex and Preconativ gave no significant changes. Preconativ is prepared without addition of heparin during the procedure.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D004285:Dogs; D005164:Factor IX / Q000009:adverse effects; D005342:Fibrinolysis / Q000187:drug effects*; D011516:Prothrombin / Q000009:adverse effects*; D013923:Thromboembolism / Q000209:etiology
D011516:Prothrombin; D005164:Factor IX